Noom Med
US$ 21.03
retatrutide phase 2 nejm weight loss 48 weeks percent This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist for Obesity — A Trial https://t.co/jNL1GNnHPT #Endocrinology Retatrutide Results: 24% Weight Loss
Description
Warning signs of significant blood loss include dizziness, lightheadedness, syncope, rapid heart rate, confusion, pale or clammy skin, and shortness of breath
This is preventive medicine and weight loss for the next generation, where we optimize for health span, not just lifespan
That distinction should factor into your decision alongside the clinical risks common to all GLP-1 medications
The differences are clinically insignificant
[DOI] [PMC free article] [PubMed] [Google Scholar] 185.Kroenke K., Spitzer R.L., Williams J.B., Lowe B
